Cutaneous T-cell lymphoma refractory

1 trials 1 recruiting MedDRA PT
1 Registered trials
1 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Prescient Therapeutics Limited Commercial
    N-[[(2S)-4-[(4-METHYL-1H-IMIDAZOL-5-YL)METHYL]-3-OXO-2-(PHENYLMETHYL)-1-PIPERAZINYL]CARBONYL]-L-LEUCINE TRIHYDRATE
    2025-521852-45-00 2 countries 2026 n=25
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Prescient Therapeutics Limited Commercial 1 Phase II 1
New trials by year
2026
1
← All indication landscapes